News

Filter

US FDA approves ThromboGenics' Jetrea; advisory backing for Aegerion's lomitapide

19-10-2012

Belgian drugmaker ThromboGenics NV (Euronext Brussels: THR) yesterday received US Food and Drug Administration…

Aegerion PharmaceuticalsCardio-vascularJetrealomitapideNorth AmericaOphthalmicsPharmaceuticalRegulationThromboGenics

Aegerion files for lomitapide approval in USA and Europe

07-03-2012

Emerging US biotech firm Aegerion Pharmaceuticals (Nasdaq: AEGR) has submitted a New Drug Application…

Aegerion PharmaceuticalsBiotechnologyEuropelomitapideNorth AmericaRare diseasesRegulation

COMPANY SPOTLIGHT

Menarini

Back to top